Publication:
Enterocin AS-48 as Evidence for the Use of Bacteriocins as New Leishmanicidal Agents

dc.contributor.authorAbengózar, María Ángeles
dc.contributor.authorCebrián, Rubén
dc.contributor.authorSaugar, Jose Maria
dc.contributor.authorGarate, Teresa
dc.contributor.authorValdivia, Eva
dc.contributor.authorMartínez-Bueno, Manuel
dc.contributor.authorMaqueda, Mercedes
dc.contributor.authorRivas, Luis
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.date.accessioned2019-06-06T11:17:24Z
dc.date.available2019-06-06T11:17:24Z
dc.date.issued2017
dc.description.abstractWe report the feasibility of enterocin AS-48, a circular cationic peptide produced by Enterococcus faecalis, as a new leishmanicidal agent. AS-48 is lethal to Leishmania promastigotes as well as to axenic and intracellular amastigotes at low micromolar concentrations, with scarce cytotoxicity to macrophages. AS-48 induced a fast bioenergetic collapse of L. donovani promastigotes but only a partial permeation of their plasma membrane with limited entrance of vital dyes, even at concentrations beyond its full lethality. Fluoresceinated AS-48 was visualized inside parasites by confocal microscopy and seen to cause mitochondrial depolarization and reactive oxygen species production. Altogether, AS-48 appeared to have a mixed leishmanicidal mechanism that includes both plasma membrane permeabilization and additional intracellular targets, with mitochondrial dysfunctionality being of special relevance. This complex leishmanicidal mechanism of AS-48 persisted even for the killing of intracellular amastigotes, as evidenced by transmission electron microscopy. We demonstrated the potentiality of AS-48 as a new and safe leishmanicidal agent, expanding the growing repertoire of eukaryotic targets for bacteriocins, and our results provide a proof of mechanism for the search of new leishmanicidal bacteriocins, whose diversity constitutes an almost endless source for new structures at moderate production cost and whose safe use on food preservation is well established.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipL.R. was supported by grants from the Fondo de Investigaciones Sanitarias-ISCIII-FEDER (PI12-02706), Plan Estatal de Investigación Científica y Técnica y de Innovación 2013-2016 (SAF2015-65740-R and SAF2013-48971-C2-1-R), Subdirección General de Redes y Centros de Investigación Cooperativa-FEDER (RICET RD12/0018/0007, RD12/0018/0011, RD16CIII/003/004, and RD16/0027/0010) and CSIC (PIE 201620E038), the European Regional Development Funds (ERDF), and the Research Group General (BIO160, UGR).es_ES
dc.format.number4es_ES
dc.format.volume61es_ES
dc.identifier.citationAntimicrob Agents Chemother. 2017 Mar 24;61(4). pii: e02288-16.es_ES
dc.identifier.doi10.1128/AAC.02288-16es_ES
dc.identifier.e-issn1098-6596es_ES
dc.identifier.issn0066-4804es_ES
dc.identifier.journalAntimicrobial agents and chemotherapyes_ES
dc.identifier.pubmedID28167557es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/7750
dc.language.isoenges_ES
dc.publisherAmerican Society for Microbiology (ASM)es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PI12-02706es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SAF2015-65740-Res_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/SAF2013-48971-C2-1-Res_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RD12/0018/0007es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RD12/0018/0011es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RD16CIII/003/004es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/RD16/0027/0010es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/ES/PIE201620E038es_ES
dc.relation.publisherversionhttps://doi.org/10.1128/AAC.02288-16es_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subjectAntimicrobial peptidees_ES
dc.subjectBioenergeticses_ES
dc.subjectEnterocin AS-48es_ES
dc.subjectIntracellular parasitees_ES
dc.subject.meshAdenosine Triphosphatees_ES
dc.subject.meshAntiprotozoal Agentses_ES
dc.subject.meshBacteriocinses_ES
dc.subject.meshCell Membranees_ES
dc.subject.meshCell Membrane Permeabilityes_ES
dc.subject.meshCell Survivales_ES
dc.subject.meshEnterococcus faecalises_ES
dc.subject.meshFluorescent Dyeses_ES
dc.subject.meshInhibitory Concentration 50es_ES
dc.subject.meshLeishmaniaes_ES
dc.subject.meshLife Cycle Stageses_ES
dc.subject.meshMacrophageses_ES
dc.subject.meshMicroscopy, Electrones_ES
dc.subject.meshMitochondriaes_ES
dc.subject.meshSpecies Specificityes_ES
dc.titleEnterocin AS-48 as Evidence for the Use of Bacteriocins as New Leishmanicidal Agentses_ES
dc.typejournal articlees_ES
dc.type.hasVersionAMes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication2036bb40-097f-406a-b634-f77164674c2b
relation.isAuthorOfPublication3d704a19-fdd1-4b31-97da-1c2cd59180d1
relation.isAuthorOfPublication.latestForDiscovery2036bb40-097f-406a-b634-f77164674c2b

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Enterocin AS-48 as Evidence_2107.pdf
Size:
694.57 KB
Format:
Adobe Portable Document Format